Evidence map›Paper›PMID 35491535›Full record

ArticleDiabetes, obesity & metabolism2022

Glucagon-like peptide-1 receptor agonist prescribing patterns in adolescents with type 2 diabetes.

Megan O Bensignor, Jack M Wolf, Kyle D Rudser, Aaron S Kelly, Silva Arslanian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes, obesity & metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Megan O BensignorCenter for Pediatric Obesity Medicine, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-9341-1858
Jack M WolfDivision of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.
Kyle D RudserDivision of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.
Aaron S KellyCenter for Pediatric Obesity Medicine, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
Silva ArslanianCenter for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology and Metabolism, UPMC Children's Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Funding

Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetesK23DK129721 · UNIVERSITY OF MINNESOTA · 2025 to 2025
$201k
NCATS NIH HHS UL1 TR002494NIDDK NIH HHS K23 DK129721NIH HHS UL1TR002494
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2AdolescentGlucagon-Like Peptide-1 Receptor AgonistsHumansHypoglycemic AgentsLiraglutideVenomsGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsLiraglutideVenomsantidiabetic drugexenatideGLP-1 analogueliraglutidetype 2 diabetes

Identifiers

PMID35491535
PMCPMC9177669

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.